Research

Cellular

Tirzepatide is preferred over semaglutide due to less reported side effects and enhanced benefits in promoting bone formation.

Tirzepatide may be a better option for patients needing obesity management with fewer side effects.

StrongSupportsmedium confidence
Tirzepatide was preferred over the commonly used single GLP-1 RAs as it has less reported side effects and enhanced benefits in promoting bone formation.
Sally A. Fahim et al. · Biomedicine & Pharmacotherapy · 2025

Why this rating

The review provides a comparative analysis of the two drugs.

Source

Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management

Sally A. Fahim et al. · Biomedicine & Pharmacotherapy · 2025

DOI 10.1016/j.biopha.2025.118731

reviewCited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →